B · Normal
On October 19, HSBC lowered the target price of Novo Nordisk from DKK 320 to DKK 280; the target price of AstraZeneca from 13,920 pence to 13,900 pence; and the target price of Bristol-Myers Squibb from USD 65 to USD 60.
Comments